Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
Holding MDGL?
Track your performance easily

Madrigal Pharmaceuticals (MDGL) Ownership - Who Owns Madrigal Pharmaceuticals?

1,117 Followers

Madrigal Pharmaceuticals (MDGL) Ownership Overview

29.50%29.03%1.59%15.11%24.77%
29.50% Insiders
1.59% Other Institutional Investors
15.11% ETFs
24.77% Public Companies and
Individual Investors
The ownership structure of Madrigal Pharmaceuticals (MDGL) stock is a mix of institutional, retail, and individual investors. Approximately 45.74% of the company’s stock is owned by Institutional Investors, 29.50% is owned by Insiders, and 24.77% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 11, 2024
William John Sibold
President & Ceo,director
xxxxxxxxxxxxx
$1551490
Jun 18, 2024
Robert E. Waltermire
Svp, Chief Pharma Dev
xxxxxxxxxxxxx
$532000
Jun 14, 2024
Robert E. Waltermire
Svp, Chief Pharma Dev
xxxxxxxxxxxxx
$570000
May 23, 2024
Robert E. Waltermire
Svp, Chief Pharma Dev
xxxxxxxxxxxxx
$239668

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,159,230Insider9.90%728,977,640
1,974,590Institution9.05%666,641,330
1,850,000Institution8.48%624,578,500
1,794,831Insider8.23%605,952,894
1,752,462Institution8.03%591,648,696
1,713,438Institution7.86%578,473,803
1,596,833Institution7.32%539,106,789
1,114,539Insider5.11%376,279,512
841,989Insider3.86%284,263,906
805,170Institution3.69%271,833,444

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,713,438Institution7.86%578,473,803
1,596,833Institution7.32%539,106,789
329,178Institution1.51%111,133,785
293,510Institution1.35%99,091,911
282,106Institution1.29%95,241,807
214,256Institution0.98%72,334,968
195,668Institution0.90%66,059,473
194,448Institution0.89%65,647,589
111,424Institution0.51%37,617,857
97,158Institution0.45%32,801,512

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
479,740Institution2.20%153,315,309
450,841Institution2.07%149,372,640
578,309Institution2.65%122,728,736
461,939Institution2.12%98,032,695
312,829Institution1.43%66,388,570
254,717Institution1.17%54,056,042
156,404Institution0.72%51,819,773
127,057Institution0.58%42,096,525
81,719Institution0.37%26,115,758
80,555Institution0.37%17,095,382

FAQ

Who Owns Madrigal Pharmaceuticals Inc (MDGL)?
According to the latest TipRanks data, approximately 1.59% of the company's stock is held by institutional investors, 29.50% is held by insiders, and 24.77% is held by retail investors.
    What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.59% of Madrigal Pharmaceuticals Inc (MDGL) stock is held by institutional investors.
      What percentage of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 24.77% of Madrigal Pharmaceuticals Inc (MDGL) stock is held by retail investors.
        Who owns the most shares of Madrigal Pharmaceuticals Inc (MDGL)?
        Behzad Aghazadeh owns the most shares of Madrigal Pharmaceuticals Inc (MDGL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis